9160 related articles for article (PubMed ID: 10321535)
1. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin.
Wang I; Bauer B; Andersson-Engels S; Svanberg S; Svanberg K
Acta Ophthalmol Scand; 1999 Apr; 77(2):182-8. PubMed ID: 10321535
[TBL] [Abstract][Full Text] [Related]
2. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion.
Hürlimann AF; Hänggi G; Panizzon RG
Dermatology; 1998; 197(3):248-54. PubMed ID: 9812030
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid.
Soler AM; Warloe T; Tausjø J; Giercksky KE
Acta Oncol; 2000; 39(5):605-9. PubMed ID: 11093368
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic diagnosis of basal cell carcinoma on the lower eyelid using topical 5-aminolaevulinic acid and desferrioxamine.
Ninomiya Y; Itoh Y; Henta T; Ishibashi A
Br J Dermatol; 1999 Sep; 141(3):580-1. PubMed ID: 10583079
[No Abstract] [Full Text] [Related]
7. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
8. [Photodynamic therapy of eyelid basalioma after topical administration of delta-aminolevulinic acid].
Hoerauf H; Hüttmann G; Diddens H; Thiele B; Laqua H
Ophthalmologe; 1994 Dec; 91(6):824-9. PubMed ID: 7849439
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response.
Morton CA; MacKie RM; Whitehurst C; Moore JV; McColl JH
Arch Dermatol; 1998 Feb; 134(2):248-9. PubMed ID: 9487227
[No Abstract] [Full Text] [Related]
10. Photodynamic therapy of eyelid basal cell carcinoma.
Kotimäki J
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1083-7. PubMed ID: 19470065
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.
Orenstein A; Haik J; Tamir J; Winkler E; Trau H; Malik Z; Kostenich G
Dermatol Surg; 2000 Aug; 26(8):765-9; discussion 769-70. PubMed ID: 10940064
[TBL] [Abstract][Full Text] [Related]
13. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
14. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.
Svanberg K; Andersson T; Killander D; Wang I; Stenram U; Andersson-Engels S; Berg R; Johansson J; Svanberg S
Br J Dermatol; 1994 Jun; 130(6):743-51. PubMed ID: 8011500
[TBL] [Abstract][Full Text] [Related]
16. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
17. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study.
Soler AM; Warloe T; Tausjø J; Berner A
Acta Derm Venereol; 1999 May; 79(3):204-6. PubMed ID: 10384917
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of nodular basal cell carcinoma with multifiber contact light delivery.
Thompson MS; Andersson-Engels S; Svanberg S; Johansson T; Palsson S; Bendsoe N; Derjabo A; Kapostins J; Stenram U; Spigulis J; Svanberg K
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):411-24. PubMed ID: 16566732
[TBL] [Abstract][Full Text] [Related]
20. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.
Coors EA; von den Driesch P
J Am Acad Dermatol; 2004 Mar; 50(3):363-7. PubMed ID: 14988676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
